Wahl Bryan

CIK 00018414011 companyIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001841401

Recent Transactions

39 trades

Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-03-05+17,161→ 17,161 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2026-03-05+27,310→ 27,310 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-20$50.11/sh−3,084→ 51,712 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-19$47.40/sh−3,261→ 54,796 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-18$46.29/sh−3,341→ 58,057 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−4,790→ 4,790 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-15+19,213→ 61,398 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−7,175→ 21,527 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−7,248→ 14,497 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-05+20,089→ 20,089 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2025-03-05+30,628→ 30,628 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-03-18$30.60/sh−4,436→ 40,951 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-03-15+12,038→ 45,387 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-15−7,248→ 21,745 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-15−4,790→ 9,580 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-07+28,702→ 28,702 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2024-03-07+42,500→ 42,500 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-11-30$16.31/sh−8,356→ 31,966 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-11-29−23,920→ 0 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-11-29+23,920→ 40,322 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-23$12.15/sh−371→ 16,402 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-22$12.64/sh−357→ 16,773 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-21$12.89/sh−350→ 17,130 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-20$12.61/sh−357→ 17,480 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-17$13.28/sh−339→ 17,837 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-16$13.43/sh−337→ 18,176 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-03-15−4,790→ 14,370 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-15+4,790→ 18,513 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2023-03-08+42,802→ 42,802 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-03-08+28,993→ 28,993 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-12-02$16.90/sh−1,154→ 13,723 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-12-01$16.75/sh−1,164→ 14,877 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-11-30$16.50/sh−1,183→ 16,041 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2022-11-29−10,251→ 23,920 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-11-29+10,251→ 17,224 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2022-03-09+65,312→ 65,312 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2022-03-09+34,171→ 34,171 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2022-03-09+19,160→ 19,160 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2021-02-02+89,368→ 89,368 total

Companies

Tarsus Pharmaceuticals, Inc.
General Counsel
$TARS

Recent Filings

Address

C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160

IRVINE, CA, 92618

View on SEC.gov